Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Structural Basis for Ligand Recognition and Functional Selectivity at Angiotensin Receptor
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 49, Pages 29127-29139
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-09-30
DOI
10.1074/jbc.m115.689000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structure of the Angiotensin Receptor Revealed by Serial Femtosecond Crystallography
- (2015) Haitao Zhang et al. CELL
- Structural determinants for binding, activation, and functional selectivity of the angiotensin AT1 receptor
- (2014) P. Balakumar et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Molecular control of δ-opioid receptor signalling
- (2014) Gustavo Fenalti et al. NATURE
- Preparation of microcrystals in lipidic cubic phase for serial femtosecond crystallography
- (2014) Wei Liu et al. Nature Protocols
- Allosteric sodium in class A GPCR signaling
- (2014) Vsevolod Katritch et al. TRENDS IN BIOCHEMICAL SCIENCES
- Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography
- (2014) Uwe Weierstall et al. Nature Communications
- Class- and Molecule-specific Differential Effects of Angiotensin II Type 1 Receptor Blockers
- (2013) Satoshi Imaizumi et al. CURRENT PHARMACEUTICAL DESIGN
- Reassessment of the Unique Mode of Binding between Angiotensin II Type 1 Receptor and Their Blockers
- (2013) Shin-Ichiro Miura et al. PLoS One
- Serial Femtosecond Crystallography of G Protein-Coupled Receptors
- (2013) W. Liu et al. SCIENCE
- Structure-Function of the G Protein–Coupled Receptor Superfamily
- (2012) Vsevolod Katritch et al. Annual Review of Pharmacology and Toxicology
- Unique binding behavior of the recently approved angiotensin II receptor blocker azilsartan compared with that of candesartan
- (2012) Shin-ichiro Miura et al. HYPERTENSION RESEARCH
- Long Range Effect of Mutations on Specific Conformational Changes in the Extracellular Loop 2 of Angiotensin II Type 1 Receptor
- (2012) Hamiyet Unal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small Molecules with Similar Structures Exhibit Agonist, Neutral Antagonist or Inverse Agonist Activity toward Angiotensin II Type 1 Receptor
- (2012) Shin-ichiro Miura et al. PLoS One
- Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions
- (2012) W. Liu et al. SCIENCE
- Fusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors
- (2012) Eugene Chun et al. STRUCTURE
- Overview of theCCP4 suite and current developments
- (2011) Martyn D. Winn et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- XDS
- (2010) Wolfgang Kabsch ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- PHENIX: a comprehensive Python-based system for macromolecular structure solution
- (2010) Paul D. Adams et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Ligand-specific Conformation of Extracellular Loop-2 in the Angiotensin II Type 1 Receptor
- (2010) Hamiyet Unal et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Conserved Binding Mode of Human β2Adrenergic Receptor Inverse Agonists and Antagonist Revealed by X-ray Crystallography
- (2010) Daniel Wacker et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- MolProbity: all-atom structure validation for macromolecular crystallography
- (2009) Vincent B. Chen et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Crystallizing membrane proteins using lipidic mesophases
- (2009) Martin Caffrey et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started